Home
About
Publications Trends
Recent Publications
Expert Search
Archive
cost minimization analysis (cma)
When is CMA Applicable?
CMA is appropriate when the interventions being compared have demonstrated equivalent clinical effectiveness. This equivalence must be established through rigorous
clinical trials
or epidemiological studies. If the outcomes are not equivalent, other forms of economic evaluations such as
cost-effectiveness analysis (CEA)
,
cost-utility analysis (CUA)
, or
cost-benefit analysis (CBA)
would be more suitable.
Frequently asked queries:
When is CMA Applicable?
How to Conduct a CMA?
What is the Role of Telemedicine?
What is COVID-19?
What Types of Health Screenings Exist?
What are Intermediate Scenarios?
3. What Preventive Measures Can Be Taken?
What are the Core Components of FETP?
How is Evidence Assessed?
How Do Health Educators Utilize Epidemiological Data?
Why is the Irregular Component Important?
What are the Key Components of Successful International Collaborations?
What are Environmental Hazards?
How has Technology Influenced Epidemiology?
How Do CD8+ T Cells Function?
What is Patient Satisfaction?
Why is Non-linearity Important?
What is Electron Microscopy?
How Do Environmental Factors Interact with Genetic Susceptibility?
How Are Patient Records Used in Epidemiological Research?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Andes Virus
COVID-19 Patients
Field Epidemiology
Genetic Diagnosis
Genetic Variants
Global Health
Public Health Education
Partnered Content Networks
Relevant Topics
active learning
African Populations
Andes virus
APOL1
arrhythmias
blended learning
cardiac complications
Chronic Kidney Disease
COVID-19
Disease Prevention
disease surveillance
emerging diseases
epidemiology
Epidemiology Training Laboratory Diagnostics
Evolutionary Genetics
experiential learning
Field Epidemiology
Field Epidemiology Training Programs
fieldwork
FSGS
genetic counseling
genetic testing
Genetic Variants
global disease monitoring
Global Health Capacity
Global health security
Global Health Security Agenda
H-ESKD
hantavirus
hantavirus pulmonary syndrome
Health Security
heart failure
hereditary paragangliomas
HIF pathway
human-to-human transmission
infectious diseases
internships
Kidney Disease
laboratory networks
Laboratory Training Programs
myocardial injury
myocarditis
Outbreak Investigation
outbreak response
pedagogy
person-to-person transmission
pseudo-hypoxia
Public Health
Public health education
public health infrastructure
public health practice
public health strategies
Public Health Workforce
renal cell carcinoma
respiratory transmission
SDH mutations
Surveillance Systems
technology in education
thromboembolism
tumorigenesis
viral outbreaks
zoonotic diseases
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Epidemiology.
Subscribe